U.S., Oct. 2 -- ClinicalTrials.gov registry received information related to the study (NCT07202429) titled 'Additive Role of ADC Value to ORADS in Adnexal Lesions' on Sept. 06, 2023.
Brief Summary: Evaluation of the impact of adding mean apparent diffusion coefficient (ADC mean) measurements to the Ovarian-Adnexal Imaging Reporting and Data System MRI (O-RADS MRI) scoring for adnexal lesion characterization using a combined O-RADS MRI/ADC mean reading approach.
Study Start Date: March 01, 2023
Study Type: OBSERVATIONAL
Condition:
Ovarian Neoplasms
Intervention:
DEVICE: MRI
"Multiparametric MRI of adnexal lesions, including conventional sequences, diffusion-weighted imaging (DWI) with apparent diffusion coefficient (ADC) measurement,...